Main navigation
|
 |
| |
Medicines |
Main content
 |
Essential Medicines and Pharmaceutical Policies (EMP)
WHO’s goal in medicines is to help save lives and improve health by ensuring the quality, efficacy, safety and rational use of medicines, including traditional medicines. Our vision is that people everywhere have access to the essential medicines they need; that the medicines are safe, effective, and of good quality; and prescribed and used rationally.
To improve on the delivery of this goal and vision, the former Department of Medicines Policy and Standards and Department of Technical Cooperation for Essential Drugs and Traditional Medicine have been combined to create one Essential Medicines and Pharmaceutical Policies Department. This merger and renaming of the department does not indicate that any one component is less of a priority, rather that together we can better deliver on all priorities in a more coordinated way. Visit "'About us'" to learn more.
A new WHO Medicines Strategy for 2008-2013 is being developed. Your comments and input on the draft strategy are valued contributions to making this a strong guiding document. Visit "'News and Events'" to review the draft strategy document and learn more about the process.

Areas of work
|
Medicines Policy
National drug policies, Technical cooperation, Medicines strategy
Financing and Supply Management
Finance, Prices, Supply management
Quality & Safety
Norms and standards, Alerts, GMP, ICDRA, INN, The International Pharmacopoeia, Quality assurance, Pharmacovigilance
Prequalification of Medicines
WHO-UNICEF-UN Project
Controlled Substances
Substance evaluation for drug control treaties Access to controlled medications
|
 |
 |
 |
Selection and Rational Use
Selection and use of medicines, rational use
Intellectual Property Rights
IPRs, WTO, TRIPS
Technical Cooperation
Pharmaceutical situation analysis, NMP, medicine prices, Procurement and supply management
Traditional Medicine
Complementary, Traditional and Herbal Medicine
Quality Assurance and Safety: Blood Products and related Biologicals
QAS, Norms and standards, Biological reference preparations, GMP
|
HSS cluster and resources
|
Essential health technologies (EHT)
|
 |
|
 |
 |

LATEST NEWS AND EVENTS
13th International Conference of Drug Regulatory Authorities
See more...
47th INN Consultation
See more...
First WHO Model List of Essential Medicines for Children
See more...
WHO Congress on Traditional Medicine
See more...
Events archive
See more...
 |
Contact information |
 |
 |
 |
World Health Organization
Department of Essential Medicines and Pharmaceutical Policies
(HSS/EMP)
20 Avenue Appia
1211, Geneva 27
Switzerland
Tel: +41 22 791 3834
Fax: +41 22 791 4743
Email: empinfo@who.int |
 |
 |
WHO Drug Information
Drug Alerts
See more...
LATEST PUBLICATION
Essential Medicines Biennial Report 2006–2007
Read more...
WHO Operational package for assessing, monitoring and evaluating country pharmaceutical situations
Read more...
Measuring Medicine Prices, Availability, Affordability and Price Components
Read more...
WHO Pharmaceuticals Newsletter
No. 2, 2008
Read more...
WHO Drug Information Volume 22, Number 1, 2008
Publications centre
|
|